MJA
MJA

Premature ejaculation: a clinical update

Med J Aust 2008; 188 (11): 662-666.
  • Neil R Palmer1
  • Bronwyn G A Stuckey1,2,3

  • 1 Keogh Institute for Medical Research, Sir Charles Gairdner Hospital, Perth, WA.
  • 2 Department of Endocrinology and Diabetes, Sir Charles Gairdner Hospital, Perth, WA.
  • 3 School of Medicine and Pharmacology, University of Western Australia, Perth, WA.


Acknowledgements: 

We would like to thank Mrs Carolyn Bond for help with typing the manuscript and Dr Terry Burgess for assistance with the diagram.

Competing interests:

Bronwyn Stuckey is on a Pfizer advisory board for female sexual dysfunction.

  • 1. American Psychiatric Association. Diagnostic and statistical manual of mental disorders. 4th ed. Washington, DC: APA, 2000.
  • 2. Waldinger MD, Berendsen HH, Blok BF, et al. Premature ejaculation and serotonergic antidepressants-induced delayed ejaculation: the involvement of the serotonergic system. Behav Brain Res 1998; 92: 111-118.
  • 3. International Society for Sexual Medicine. ISSM definition of premature ejaculation. http://www.issm.info/prod/system/main/index.asp (accessed Mar 2008).
  • 4. Waldinger MD. Premature ejaculation: state of the art. Urol Clin North Am 2007; 34: 591-599.
  • 5. Astbury-Ward E. From Kama Sutra to dot.com: the history, myths and management of premature ejaculation. Sex Relat Ther 2002; 17: 367-379.
  • 6. Rosen RC. Prevalence and risk factors of sexual dysfunction in men and women. Curr Psychiatry Rep 2000; 2: 189-195.
  • 7. Waldinger MD, Rietschel M, Nöthen MM, et al. Familial occurrence of primary premature ejaculation. Psychiatr Genet 1998; 8: 37-40.
  • 8. Hite S. The Hite report: study of male sexuality. 2nd ed. London: Ebury Press, 1990.
  • 9. Masters WH, Johnson VE. Human sexual inadequacy. Boston: Little Brown, 1970.
  • 10. Waldinger MD, Quinn P, Dilleen M, et al. A multinational population survey of intravaginal ejaculation latency time. J Sex Med 2005; 2: 492-497.
  • 11. Waldinger MD. The neurobiological approach to premature ejaculation. J Urol 2002; 168: 2359-2367.
  • 12. Kimura Y, Miyamoto A, Urano S, et al. The spinal monoaminergic systems relating to ejaculation. I. Ejaculation and dopamine. Andrologia 1982; 14: 341-346.
  • 13. Waldinger MD, Olivier B. Selective serotonin reuptake inhibitor-induced sexual dysfunction: clinical and research considerations. Int Clin Psychopharmacol 1998; 13 Suppl 6: S27-S33.
  • 14. Patrick DL, Rowland D, Rothman M. Interrelationships among measures of premature ejaculation: the central role of perceived control. J Sex Med 2007; 4: 780-788.
  • 15. Carani C, Isidori AM, Granata A, et al. Multicenter study on the prevalence of sexual symptoms in male hypo- and hyperthyroid patients. J Clin Endocrinol Metab 2005; 90: 6472-6479.
  • 16. Semans JH. Premature ejaculation: a new approach. South Med J 1956; 49: 353-358.
  • 17. Wolpe J, Lazarus AA. Behavior therapy techniques: a guide to the therapy of neuroses. New York: Pergamon, 1968.
  • 18. Dinsmore WW, Hackett G, Goldmeier D, et al. Topical eutectic mixture for premature ejaculation (TEMPE): a novel aerosol-delivery form of lidocaine–prilocaine for treating premature ejaculation. BJU Int 2007; 99: 369-375.
  • 19. Busato W, Galindo CC. Topical anaesthetic use for treating premature ejaculation: a double-blind, randomized, placebo-controlled study. BJU Int 2004; 93: 1018-1021.
  • 20. Choi HK, Jung GW, Moon KH, et al. Clinical study of SS-cream in patients with lifelong premature ejaculation. Urology 2000; 55: 257-261.
  • 21. Sharlip ID. Guidelines for the diagnosis and management of premature ejaculation. J Sex Med 2006; 3 Suppl 4: 309-317.
  • 22. Kim SC, Seo KK. Efficacy and safety of fluoxetine, sertraline and clomipramine in patients with premature ejaculation: a double-blind, placebo controlled study. J Urol 1998; 159: 425-427.
  • 23. Althof SE, Levine SB, Corty EW, et al. A double-blind crossover trial of clomipramine for rapid ejaculation in 15 couples. J Clin Psychiatry 1995; 56: 402-407.
  • 24. McMahon CG. Treatment of premature ejaculation with sertraline hydrochloride: a single-blind placebo controlled crossover study. J Urol 1998; 159: 1935-1938.
  • 25. McMahon CG, Touma K. Treatment of premature ejaculation with paroxetine hydrochloride. Int J Impot Res 1999; 11: 241-245.
  • 26. de Jong TR, Veening JG, Olivier B, Waldinger MD. Oxytocin involvement in SSRI-induced delayed ejaculation: a review of animal studies. J Sex Med 2007; 4: 14-28.
  • 27. McMahon CG, Touma K. Treatment of premature ejaculation with paroxetine hydrochloride as needed: 2 single-blind placebo controlled crossover studies. J Urol 1999; 161: 1826-1830.
  • 28. Pryor JL, Althof SE, Steidle C, et al. Efficacy and tolerability of dapoxetine in treatment of premature ejaculation: an integrated analysis of two double-blind, randomised controlled trials. Lancet 2006; 368: 929-937.
  • 29. McMahon CG, Stuckey BG, Andersen M, et al. Efficacy of sildenafil citrate (Viagra) in men with premature ejaculation. J Sex Med 2005; 2: 368-375.
  • 30. Waldinger MD, Zwinderman AH, Olivier B, Schweitzer DH. The majority of men with lifelong premature ejaculation prefer daily drug treatment: an observation study in a consecutive group of Dutch men. J Sex Med 2007; 4: 1028-1037.
  • 31. Assalian P. Guidelines for the pharmacotherapy of premature ejaculation. World J Urol 2005; 23: 127-129.
  • 32. Salonia A, Maga T, Colombo R, et al. A prospective study comparing paroxetine alone versus paroxetine plus sildenafil in patients with premature ejaculation. J Urol 2002; 168: 2486-2489.
  • 33. Chen J, Mabjeesh NJ, Matzkin H, Greenstein A. Efficacy of sildenafil as adjuvant therapy to selective serotonin reuptake inhibitor in alleviating premature ejaculation. Urology 2003; 61: 197-200.
  • 34. Earle CM, Stuckey BG, Ching HL, Wisniewski ZS. The incidence and management of priapism in Western Australia: a 16 year audit. Int J Impot Res 2003; 15: 272-276.
  • 35. Chew KK, Stuckey BG, Earle CM, et al. Penile fibrosis in intracavernosal prostaglandin E1 injection therapy for erectile dysfunction. Int J Impot Res 1997; 9: 225-229.

Author

remove_circle_outline Delete Author
add_circle_outline Add Author

Comment
Do you have any competing interests to declare? *

I/we agree to assign copyright to the Medical Journal of Australia and agree to the Conditions of publication *
I/we agree to the Terms of use of the Medical Journal of Australia *
Email me when people comment on this article